These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17662910)

  • 1. Pigmentary disorders in Western countries.
    van der Veen JP
    Dermatol Clin; 2007 Jul; 25(3):449-55, x-xi. PubMed ID: 17662910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study.
    Taylor A; Pawaskar M; Taylor SL; Balkrishnan R; Feldman SR
    J Cosmet Dermatol; 2008 Sep; 7(3):164-8. PubMed ID: 18789050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The practice guideline 'vitiligo'].
    Menke HE; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1976-81. PubMed ID: 17002186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin pigmentary disorders: treatment update.
    Ortonne JP; Passeron T
    Dermatol Clin; 2005 Apr; 23(2):209-26. PubMed ID: 15837152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of vitiligo: patient characteristics associated with quality of life.
    Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
    J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' evaluation of quality of care in general practice: what are the cultural and linguistic barriers?
    Harmsen JA; Bernsen RM; Bruijnzeels MA; Meeuwesen L
    Patient Educ Couns; 2008 Jul; 72(1):155-62. PubMed ID: 18485657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interventions for vitiligo.
    Whitton ME; Ashcroft DM; González U
    J Am Acad Dermatol; 2008 Oct; 59(4):713-7. PubMed ID: 18793940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo.
    Nurs Times; 2005 May 31-Jun 6; 101(22):28. PubMed ID: 15960103
    [No Abstract]   [Full Text] [Related]  

  • 15. Pigmentary disorders in the Mediterranean area.
    El-Mofty MA; Esmat SM; Abdel-Halim MR
    Dermatol Clin; 2007 Jul; 25(3):401-17, x. PubMed ID: 17662906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cosmetic camouflage for a better quality of life].
    Deshayes P
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S372-4. PubMed ID: 19931700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmentary disorders in China.
    Zhang XJ; Yang S; Gao M
    Dermatol Clin; 2007 Jul; 25(3):439-47, x. PubMed ID: 17662909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with universal vitiligo and health-related quality of life.
    Linthorst Homan MW; Sprangers MA; de Korte J; Bos JD; van der Veen JP
    Arch Dermatol; 2008 Aug; 144(8):1062-4. PubMed ID: 18711089
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia.
    Al Robaee AA
    Saudi Med J; 2007 Sep; 28(9):1414-7. PubMed ID: 17768471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.